Advice
Following an abbreviated submission
budesonide CFC-free inhaler (Pulmicort) is accepted for use in NHS Scotland for the treatment of asthma.
Budesonide CFC-free inhaler (Pulmicort) (hydrofluoroalkanes [HFA] pressurised metered dose inhaler [pMDI]) replaces the equivalent CFC-containing pMDI formulations at a similar cost per microgram.
Download detailed advice44KB (PDF)
Medicine details
- Medicine name:
- budesonide (Pulmicort)
- SMC ID:
- 536/09
- Indication:
- Asthma
- Pharmaceutical company
- AstraZeneca UK Ltd
- BNF chapter
- Respiratory system
- Submission type
- Abbreviated
- Status
- Accepted
- Date advice published
- 14 April 2009